Zimbabwe
Medicines and Allied Substances Control Act
Chapter 15:03
- Commenced on 1 September 1969
- [This is the version of this document at 31 December 2016 and includes any amendments published up to 31 December 2017.]
- [Note: This version of the Act was revised and consolidated by the Law Development Commission of Zimbabwe]
Part I – Preliminary
1. Short title
This Act may be cited as the Medicines and Allied Substances Control Act [Chapter 15:03].[section as amended by section 2 of Act 1 of 1996]2. Interpretation
Part II – Medicines Control Authority
3. Establishment of Medicines Control Authority of Zimbabwe
There is hereby established an authority, to be known as the Medicines Control Authority of Zimbabwe, which shall be a body corporate capable, in its corporate name, of suing and being sued and, subject to this Act, of performing all acts that bodies corporate may by law perform.[section as substituted by section 4 of Act 1 of 1996]3A. Succession to former Council
The Authority shall for all purposes be the successor to the former Council.[section inserted by section 4 of Act 1 of 1996]4. Constitution of Authority
5. Conditions of office of members
6. Disqualification for appointment as member
7. Vacation of office of member
A member shall vacate his office and his office shall become vacant—8. Minister may require member to vacate office or suspend him
9. Filling of vacancies on Authority
On the death of, or vacation of office by, a member, the Minister may, subject to this Part, appoint a person to fill the vacancy:Provided that, if as a result of the vacancy the number of members is fewer than the minimum specified in subsection (1) of section four, the Minister shall appoint a person to fill the vacancy.[section as substituted by section 10 of Act 1 of 1996]10. Meetings and procedure of Authority
11. Committees of Authority
12. Remuneration and expenses of members of Authority or committee
A member of the Authority or of a committee of the Authority shall be paid from the funds of the Authority such allowances as the Minister, after consultation with the Authority, may fix.[section as amended by section 13 of Act 1 of 1996]12A. Disclosure of interest by members of Authority and committees
13. Funds, accounts and audit
13A. Annual report of Authority
14. Powers of Authority
For the better exercise of its functions the Authority shall, subject to this Act, have power to do or cause to be done all or any of the things specified in the First Schedule.[section as substituted by section 17 of Act 1 of 1996]14A. Pensions benefits for certain employees of Authority
With the approval of the Public Service Commission and the Minister responsible for finance, the Authority may require any of its employees who have been transferred from the Public Service to the service of the Authority to continue paying contributions to the Consolidated Revenue Fund for pensions purposes, and thereupon—15. Validity of decisions and acts of Authority
No decision or act of the Authority or act done under the authority of the Authority shall be invalid by reason only of the fact that—Part III – Clinical trials
16. Conduct of Clinical trials
17. Application for conduct of clinical trials
18. Director-General to submit applications to Authority
19. Conditions for conduct of clinical trials
20. Consents for clinical trials
21. Supply of information prior to clinical trials etc.
22. Council’s power to stop or suspend clinical trials
If at any stage during the clinical trial of any medicine authorized in terms of section eighteen, the Authority is satisfied that having due regard to the initial risks, discomforts or other adverse effects caused to persons or animals taking part in the trial it is in the public interest to stop or suspend the trial, it shall seek and obtain forthwith the Secretary’s written approval to stop or suspend the trial immediately, and, if such approval is obtained, the Authority shall notify in writing the person conducting the trial accordingly.23. Monitoring of clinical trials by Authority
To ensure adequate protection of the general public against any risks or adverse effects from the clinical trial of any medicine authorized in terms of section eighteen, the Authority shall monitor such clinical trial from the beginning to the end so as to satisfy itself that all specific and general conditions subject to which the trial was authorized are being strictly observed by the person conducting the trial, and that to all intents and purposes the trial will achieve its aims and objectives.24. Reports on clinical trials
25. ***
[section repealed by section 4 of Act 22 of 2001]Part IIIA – Zimbabwe Regional Medicines Control Laboratory
25A. Transfer of Laboratory to Authority
With effect from the 1st August, 1997—25B. Functions of Laboratory
The Laboratory shall be responsible for—25C. Director of Laboratory
Part IV – Registration of medicines
26. Director-General of Authority
27. Medicines Register
28. Declaration of specified medicines
29. Sale of specified medicines
30. Registrability of medicines
31. Applications for registration of medicines
32. Lapsing of application for registration of medicine
If the annual fee payable for the retention of the right to sell an unregistered specified medicine referred to in subsection (2) of section twenty-nine is not paid within such period as may be prescribed, the application for the registration of that medicine shall lapse forthwith, and the Director-General shall cause notification thereof to be published in the Gazette.33. Registration of medicines
34. Cancellation and variation of conditions of registration
35. Notifications in professional journals
36. Medicines to be labelled
37. ***
[section repealed by section 22 of Act 1 of 1996]38. Prohibitions, controls and restrictions in respect of medicines, veterinary medicines and certain substances, devices and articles
39. Prohibition on sale of medicines which do not comply with prescribed requirements and furnishing of information regarding medicines to Authority
40. Advertisement of medicines
41. Prohibition of sale of undesirable medicines
Part V – Prohibited drugs
[Part V repealed by section 282 of Act 23 of 2004]42. ***
[section repealed by section 282 of Act 23 of 2004]43. ***
[section repealed by section 282 of Act 23 of 2004]44. ***
[section repealed by section 282 of Act 23 of 2004]45. ***
[section repealed by section 282 of Act 23 of 2004]46. ***
[section repealed by section 282 of Act 23 of 2004]47. ***
[section repealed by section 282 of Act 23 of 2004]48. ***
[section repealed by section 282 of Act 23 of 2004]49. ***
[section repealed by section 282 of Act 23 of 2004]50. ***
[section repealed by section 282 of Act 23 of 2004]51. ***
[section repealed by section 282 of Act 23 of 2004]52. ***
[section repealed by section 282 of Act 23 of 2004]Part VI – Licensing and control of pharmaceutical premises and persons
53. Interpretation in Part VI
In this Part—“designated health institution” [definition repealed by section 24 of Act 1 of 1996]“dispense”, in relation to a medicine, means to—(a)prepare; or(b)count out, measure or decant from a bulk supply; or(c)mix; or(d)dissolve; or(e)disperse;and dispose of the medicine, for gain or otherwise, for the treatment of a particular person or animal but does not include the actual administration of the medicine.54. Register of licensed premises and persons
The Director-General shall keep and maintain in a form approved by the Authority a register of all premises which have been licensed and all persons who have been licensed in terms of this Part in which he shall record such particulars as may be directed by the Authority, the conditions, if any, imposed upon such licences and the cancellation, suspension or renewal of such licences.55. Premises and persons to be licensed
56. Application for licence
57. Licensing of premises
58. Licensing of persons
59. General disqualifications for licences
60. Validity and renewal of licences
61. Cancellation, suspension, alteration and variation of licences
Part VII – Appeals
62. Appeals
Any person who is aggrieved by a decision of the Authority in terms of this Act may, within thirty days after the date of that decision, appeal by notice in writing to the Administrative Court.Part VIII – General
63. Compounding or dispensing of medicines and veterinary medicines
64. Exemption of Authority from liability
No liability shall attach to the Authority or any committee thereof or to a member of the Authority or any committee thereof for any loss or damage sustained by any person as a result of the bona fide exercise or performance by the Authority or any committee thereof of any power or duty conferred or imposed upon the Authority by this Act:Provided that the provisions of this section shall not be construed so as to prevent any person from recovering by action in any competent court compensation for any loss or damage sustained by him which was caused by negligence.65. Appointment of inspectors and analysts for purposes of this Act
66. Powers of inspectors
67. Offences and penalties
68. ***
[section repealed by section 4 of Act 22 of 2001]69. Special jurisdiction of magistrates courts
Notwithstanding anything to the contrary contained in the Magistrates Court Act [Chapter 7:10]—70. Procedure and evidence
70A. Registers as evidence
71. Special defence for contravention of section 39
It shall be a sufficient defence for a person charged with the sale of a medicine in contravention of section thirty-nine if he proves to the satisfaction of the court that he had no reason to believe that that medicine did not so comply.72. Act or omission by manager, agent or employee
73. Preservation of secrecy
73A. Laboratory fees
The Authority may, with the approval of the Minister, levy fees for any analysis, service or thing done by the Laboratory in the course of its functions.[section inserted by section 33 of Act 1 of 1996]74. Regulations
75. Exemptions
The Authority may, in writing, exempt, subject to such conditions as it may specify, any medicine or substance from the operation of any or all of the provisions of this Act.[section as substituted by section 35 of Act 1 of 1996]76. Savings and transitional provisions
The Third Schedule shall apply in relation to the succession of the Authority to the former Council and other matters connected with or incidental to the coming into effect of the Drugs and Allied Substances Amendment Act, 1996 on the 1st August 1997.History of this document
31 December 2016 this version
Consolidation
01 September 1969
Commenced